Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Clinical trial NCT04568902 · COMPLETED
Trial details
- NCT number
- NCT04568902
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2025-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.